Scientist, mRNA/DNA NGS Analytics Platform

Il y a 3 jours

Rixensart, Waals-Brabant, Belgique GlaxoSmithKline Temps plein 59 000 € - 99 000 € Contrat

GlaxoSmithKline in Belgium seeks a Scientist in the Molecular Analytics Platform to develop and execute NAT-based sequencing methods for mRNA vaccines. You will focus on sequencing and characterizing nucleic acids using Illumina and Oxford Nanopore tech, reporting results, and ensuring QA/regulatory alignment.

The role requires a PhD with post-doctoral experience and 5+ years in analytical vaccine sciences, with collaboration across Belgium and US teams.